logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

NSCLC: atezolizumab slows time to new brain lesions vs docetaxel

Atezolizumab also offered better OS in patients with no history of brain metastasis.